Puma Biotechnology (PBYI) Return on Sales Growth (5y) (2022 - 2026)

Puma Biotechnology (PBYI) Return on Sales Growth (5y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,222.41 Bn 67,222.13 Bn -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.12 Bn 466.33 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.84 Bn 114.59 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.89 Bn 61.14 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 55.83 Bn 50.64 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.34 Bn 34.34 Bn 959.66 Mn
10 Puma Biotechnology 409.81 Mn 371.53 Mn 34.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 1.00
Sep 30, 2025 1.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 1.00
Jun 30, 2024 1.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 1.00
Jun 30, 2023 2.00
Mar 31, 2023 0.00
Dec 31, 2022 3.00
Sep 30, 2022 65.00